Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, ...

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

Moderna shares are down for the second day in a row after the company said it would slash its research and development costs.

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

R&D Day, Moderna MRNA announcedseveral updates about the advancements in its pipeline and its business outlook for the next ...

Over $27 million in Department of Defense funding has been awarded for the New York-based Northeast Regional Defense ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

The research arm of Mercedes-Benz in North America, which is focused on delivering personalized, digital experiences for ...